These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21177463)

  • 1. Field evaluation of the accuracy of vaccine deposition by two different commercially available in ovo injection systems.
    Williams CJ; Hopkins BA
    Poult Sci; 2011 Jan; 90(1):223-6. PubMed ID: 21177463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of in ovo vaccine delivery route on herpesvirus of turkeys/SB-1 efficacy and viremia.
    Wakenell PS; Bryan T; Schaeffer J; Avakian A; Williams C; Whitfill C
    Avian Dis; 2002; 46(2):274-80. PubMed ID: 12061635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative field evaluations of in ovo applied technology.
    Williams CJ; Zedek AS
    Poult Sci; 2010 Jan; 89(1):189-93. PubMed ID: 20008818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers.
    Sarma G; Greer W; Gildersleeve RP; Murray DL; Miles AM
    Avian Dis; 1995; 39(2):211-7. PubMed ID: 7677641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of in ovo versus subcutaneous administration of the Marek's disease vaccine and pre-placement holding time on the processing yield of Ross 708 broilers.
    Peebles ED; Barbosa TM; Cummings TS; Dickson J; Womack SK; Gerard PD
    Poult Sci; 2017 Sep; 96(11):3944-3948. PubMed ID: 29050405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications in in ovo technology.
    Johnston PA; Liu H; O'Connell T; Phelps P; Bland M; Tyczkowski J; Kemper A; Harding T; Avakian A; Haddad E; Whitfill C; Gildersleeve R; Ricks CA
    Poult Sci; 1997 Jan; 76(1):165-78. PubMed ID: 9037703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avian influenza adenovirus-vectored in ovo vaccination: target embryo tissues and combination with Marek's disease vaccine.
    Breedlove C; Minc JK; Tang DC; van Santen VL; van Ginkel FW; Toro H
    Avian Dis; 2011 Dec; 55(4):667-73. PubMed ID: 22312988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of INOVOJECT egg injection system for delivering Marek's disease vaccine under hatchery conditions.
    Marsh TE; Fluke DK; Villegas P
    Avian Dis; 1997; 41(2):452-4. PubMed ID: 9201414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In ovo evaluation of FloraMax®-B11 on Marek's disease HVT vaccine protective efficacy, hatchability, microbiota composition, morphometric analysis, and Salmonella enteritidis infection in broiler chickens.
    Teague KD; Graham LE; Dunn JR; Cheng HH; Anthony N; Latorre JD; Menconi A; Wolfenden RE; Wolfenden AD; Mahaffey BD; Baxter M; Hernandez-Velasco X; Merino-Guzman R; Bielke LR; Hargis BM; Tellez G
    Poult Sci; 2017 Jul; 96(7):2074-2082. PubMed ID: 28160004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of in ovo versus subcutaneous administration of the Marek's disease vaccine and pre-placement holding time on the early post-hatch quality of Ross × Ross 708 broiler chicks.
    Peebles ED; Barbosa TM; Cummings TS; Dickson J; Womack SK
    Poult Sci; 2016 Sep; 95(9):2038-44. PubMed ID: 27143771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fogle JE; Gimeno IM
    Vaccine; 2016 Jul; 34(35):4180-4187. PubMed ID: 27371103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of in ovo versus subcutaneous administration of the Marek's disease vaccine and pre-placement holding time on the post-hatch performance of Ross 708 broilers1,2,3.
    Peebles ED; Barbosa TM; Cummings TS; Dickson J; Womack SK; Gerard PD
    Poult Sci; 2017 May; 96(5):1071-1077. PubMed ID: 27794051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses.
    Tan J; Cooke J; Clarke N; Tannock GA
    Avian Pathol; 2007 Oct; 36(5):351-9. PubMed ID: 17899458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for inoculating Lactobacillus animalis and Enterococcus faecium alone or in combination using commercial in ovo technology without negatively impacting hatch and post-hatch performance.
    Beck CN; McDaniel CD; Wamsley KGS; Kiess AS
    Poult Sci; 2019 Dec; 98(12):7050-7062. PubMed ID: 31420659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Marek's disease vaccines on interferon and toll like receptors when administered in ovo.
    Gimeno IM; Glaize A; Cortes AL
    Vet Immunol Immunopathol; 2018 Jul; 201():62-66. PubMed ID: 29914684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In ovo vaccination technology.
    Ricks CA; Avakian A; Bryan T; Gildersleeve R; Haddad E; Ilich R; King S; Murray L; Phelps P; Poston R; Whitfill C; Williams C
    Adv Vet Med; 1999; 41():495-515. PubMed ID: 9890038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stage of broiler embryo development on coccidiosis vaccine injection accuracy, and subsequent oocyst localization and hatchling quality.
    Sokale AO; Williams CJ; Triplett MD; Hoerr FJ; Peebles ED
    Poult Sci; 2020 Jan; 99(1):189-195. PubMed ID: 32416800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
    Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
    Geerligs H; Spijkers I; Rodenberg J
    Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.